Legislative Update: Congress Extends Funding for Patient Programs
Putting Patients First Blog
SEPTEMBER 30, 2024
The goal of the rare pediatric disease PRV program is to incentivize drug development for rare pediatric diseases. With the funding deadline occurring after the November elections, the next round of negotiations will be impacted by the election results. This bill now heads to President Biden’s desk to be signed into law.
98 
Let's personalize your content